Warfarin for atrial fibrillation: The patient's perspective

Archives of Internal Medicine

Volumn 156, Issue 16, 1996, Pages 1841-1848

  Man Son Hing, Malcolm ^a,b   Laupacis, Andreas ^a,b   O'Connor, Annette ^b,c   Wells, George ^a,b   Lemelin, Jacques ^c   Wood, William ^c   Dermer, Mark ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; DRUG EFFICACY; DRUG SCREENING; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR DISORDERS; HUMANS; MIDDLE AGED; RISK; SEVERITY OF ILLNESS INDEX; WARFARIN;

EID: 0029813715     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.16.1841     Document Type: Article

References (31)

1. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407-415.
2. Petersen P, Boysen G, Godtfredsen J, Andersen E, Andersen B. Placebocontrolled, randomised trial of warfarin and aspirin for the prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study. Lancet. 1989;1:175-179.
3. The Stroke Prevention in Atrial Fibrillation Investigators. The stroke prevention in atrial fibrillation trial: final results. Circulation. 1991;84:527-539.
4. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke on patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990;323:1505-1511.
5. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C, and CAFA Co-investigators. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991;18:349-355.
6. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med. 1992; 327:1406-1412.
7. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med. 1994;154:1449-1457.
8. Laupacis A, Albers G, Dalen J, Dunn M, Feinberg W, Jacobson A. Antithrombotic therapy in atrial fibrillation. Chest. 1995;108(suppl 4):352S-359S.
9. Albers GW, Atwood JE, Hirsh J, Sherman DG, Hughes RA, Connolly SJ. Stroke prevention in nonvalvular atrial fibrillation. Ann Intern Med. 1991;115:727-735.
10. Green CJ, Hadorn D, Kazanjian A. Anticoagulation for Stroke Prevention in Chronic Non-valvular Atrial Fibrillation. Vancouver, BC: Office of Health Technology Assessment; 1995.
11. Lip GYH, Tean KN, Dunn FG, Treatment of atrial fibrillation in a district general hospital. Br Heart J. 1994;71:92-95.
12. Bath PMW, Prasad A, Brown MM, MacGregor GA. Survey of use of anticoagulation in patients with atrial fibrillation. BMJ. 1993;306:1045.
13. McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett EL. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med. 1995;155:277-281.
14. O'Connell JE, Gray C. Use of warfarin dependent on local services. BMJ. 1993; 307:1493.
15. Taylor F, Ramsay M. GPs not prepared for monitoring anticoagulation. BMJ. 1993;307:1493.
16. Rassam SMB. Anticoagulation in patients with atrial fibrillation: not safe and not cheap. BMJ. 1993;307:1492.
17. Naylor CD, Llewellyn-Thomas HA. Can there be a more patient-centred approach to determining clinically important treatment effect sizes for randomized treatment trials? J Clin Epidemiol. 1994;47:787-795.
18. Llewellyn-Thomas HA, Thiel EC, Clark RM. Patients versus surrogates: whose opinion counts on ethics review panels? Clin Res. 1989;37:501-505.
19. Llewellyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C. Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med. 1991;32:35-42.
20. Folstein MF, Folstein SE, McHugh PR. A practical method for grading the cognitive state of patients for the clinician. J Psychaitr Res. 1975;12:189-198.
21. Solomon NA, Glick HA, Russo CJ, Lee J, Schulman KA. Patient preferences for stroke outcomes. Stroke. 1994;25:1721-1725.
22. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet. 1994;343:687-691.
23. O'Connor AM, Boyd MF, Tritcher DL, Sutherland H, Till JE. Eliciting preferences for treatment for alternative cancer drug treatments. Med Decis Making. 1985;5:453-463.
24. Palda VA, Llewellyn-Thomas HA, MacKenzie RG, Pritchard KI, Harrison-Woermke DE, Naylor CD. Breast cancer patients' willingness to wait for, and forgo, radiation treatment. Med Decis Making. 1994;14:439. Abstract.
25. Lenert LA, Flowers C, Goldstein MK, Garber AM. Effect of method for search for subjects' indifference point on the reliability and validity standard gamble utilities. Med Decis Making. 1995;15:430. Abstract.
26. Percy ME, Llewellyn-Thomas H. Assessing preferences about the DNR order: does it depend on how you ask? Med Decis Making. 1995;15:209-216.
27. Slovis P, Lichtenstein S. Comparison of Bayesian and regression approaches to the study of information processing in judgement. Organizational Behav Hum Perform. 1971;6:649-744.
28. Kahneman D, Slovic P, Tversky A. Judgement Under Uncertainty: Heuristics and Biases. Cambridge, England: Cambridge University Press; 1982:14.
29. O'Connor AM, Tugwell P, Wells G. Testing a portable, self-administered decision aid for post-menopausal women considering long-term hormone replacement therapy (HRT) to prevent osteoporosis and heart disease. Med Decis Making. 1994;14:438. Abstract.
30. Levine MN, Gafni A, Markham B, MacFarlane D. A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med. 1992;117:53-58.
31. Kasper JF, Mulley AG, Wennberg JE. Developing shared decision making programs to improve the quality of health care. Quality Rev Bull. 1992;1:183-190.